Detalhe da pesquisa
1.
NCCN Guidelines® Insights: Survivorship, Version 1.2023.
J Natl Compr Canc Netw
; 21(8): 792-803, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549906
2.
NCCN Guidelines® Insights: Survivorship, Version 1.2022.
J Natl Compr Canc Netw
; 20(10): 1080-1090, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240847
3.
Survivorship, Version 1.2021.
J Natl Compr Canc Netw
; 19(6): 676-685, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214969
4.
NCCN Guidelines Insights: Survivorship, Version 2.2020.
J Natl Compr Canc Netw
; 18(8): 1016-1023, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755975
5.
Patterns of racial/ethnic disparities in baseline health-related quality of life and relationship with overall survival in patients with colorectal cancer.
Qual Life Res
; 29(11): 2977-2986, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621260
6.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol
; 185(4): 670-678, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30820940
7.
NCCN Guidelines Insights: Survivorship, Version 2.2019.
J Natl Compr Canc Netw
; 17(7): 784-794, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319383
8.
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Cancer
; 124(12): 2561-2569, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723393
9.
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(10): 1216-1247, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323092
10.
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Br J Haematol
; 176(5): 750-758, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983760
11.
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(9): 1140-1163, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874599
12.
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Cancer
; 122(20): 3145-3151, 2016 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351173
13.
NCCN Guidelines Insights: Survivorship, Version 1.2016.
J Natl Compr Canc Netw
; 14(6): 715-24, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283164
14.
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Br J Haematol
; 169(6): 814-23, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25828695
15.
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Br J Haematol
; 171(4): 509-16, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260306
16.
Survivorship: screening for cancer and treatment effects, version 2.2014.
J Natl Compr Canc Netw
; 12(11): 1526-31, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361799
17.
Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw
; 12(10): 1396-406, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313179
18.
Survivorship: immunizations and prevention of infections, version 2.2014.
J Natl Compr Canc Netw
; 12(8): 1098-111, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099442
19.
Survivorship: healthy lifestyles, version 2.2014.
J Natl Compr Canc Netw
; 12(9): 1222-37, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25190692
20.
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
Br J Haematol
; 179(3): 503-506, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378601